World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
25008
World Ranking
12890
National Ranking
5486

Overview

Xi Ping Huang is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily spans the fields of biochemistry, genetics, and molecular biology, with a significant focus on molecular biology and cellular and molecular neuroscience. They also engage in computational theory and mathematics, organic chemistry, and pharmacology within their research scope.

The main topics covered in Huang's work include receptor mechanisms and signaling, neuropeptides and animal physiology, computational drug discovery methods, neuroscience and neuropharmacology research, pharmacological receptor mechanisms and effects, neurotransmitter receptor influence on behavior, and chemical synthesis and analysis.

Huang has coauthored numerous papers with researchers such as Bryan L. Roth, Brian K. Shoichet, Yongfeng Liu, B. Krumm, and John D. McCorvy.

Their frequent publication venues include UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), Nature, OPAL (Open@LaTrobe) at La Trobe University, and Cell.

Notable recent publications by Huang feature:

  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, 2020, Nature
  • Synthon-based ligand discovery in virtual libraries of over 11 billion compounds, 2021, Nature
  • Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys, 2020, Nature Neuroscience
  • Virtual discovery of melatonin receptor ligands to modulate circadian rhythms, 2020, Nature
  • Structural insights into the human D1 and D2 dopamine receptor signaling complexes, 2021, Cell

Best Publications

  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

    David E. Gordon;Gwendolyn M. Jang;Mehdi Bouhaddou;Jiewei Xu

  • NMDAR inhibition-independent antidepressant actions of ketamine metabolites

    Panos Zanos;Ruin Moaddel;Patrick J. Morris;Polymnia Georgiou

  • Structure of the human κ-opioid receptor in complex with JDTic

    Huixian Wu;Daniel Wacker;Mauro Mileni;Vsevolod Katritch

  • Structure-based discovery of opioid analgesics with reduced side effects

    Aashish Manglik;Henry Lin;Dipendra K. Aryal;John D. McCorvy

  • Automated design of ligands to polypharmacological profiles

    Jérémy Besnard;Gian Filippo Ruda;Vincent Setola;Keren Abecassis

  • Structural Features for Functional Selectivity at Serotonin Receptors

    Daniel Wacker;Chong Wang;Vsevolod Katritch;Gye Won Han

  • PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

    Wesley K. Kroeze;Maria F. Sassano;Xi Ping Huang;Katherine Lansu

  • A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells

    Masoud Vedadi;Dalia Barsyte-Lovejoy;Feng Liu;Sylvie Rival-Gervier

  • Structural Basis for Molecular Recognition at Serotonin Receptors

    Chong Wang;Yi Jiang;Yi Jiang;Jinming Ma;Jinming Ma;Huixian Wu

  • Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.

    Aaron A. Thompson;Wei-Wei Liu;Eugene Chun;Vsevolod Katritch

  • Molecular control of δ-opioid receptor signalling

    Gustavo Fenalti;Patrick M. Giguere;Vsevolod Katritch;Xi Ping Huang

  • Structure of the human smoothened receptor bound to an antitumour agent

    Chong Wang;Huixian Wu;Vsevolod Katritch;Gye Won Han

  • An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

    Kyle D. Konze;Anqi Ma;Fengling Li;Dalia Barsyte-Lovejoy

  • A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior

    Eyal Vardy;J. Elliott Robinson;Chia Li;Chia Li;Reid H.J. Olsen

  • Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.

    Yuji Nagai;Naohisa Miyakawa;Hiroyuki Takuwa;Yukiko Hori

  • Discovery of β-Arrestin–Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy

    John A. Allen;Julianne M. Yost;Vincent Setola;Xin Chen

  • Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor

    Tao Che;Susruta Majumdar;Saheem A. Zaidi;Pauline Ondachi

  • Comprehensive characterization of the Published Kinase Inhibitor Set

    Jonathan M. Elkins;Vita Fedele;Marta Szklarz;Kamal R. Abdul Azeez

  • Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

    Atheir I. Abbas;Peter B. Hedlund;Xi Ping Huang;Thuy B. Tran

  • Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.

    Chong Wang;Huixian Wu;Tama Evron;Eyal Vardy

Frequent Co-Authors

Bryan L. Roth
Bryan L. Roth University of North Carolina at Chapel Hill
Jian Jin
Jian Jin Icahn School of Medicine at Mount Sinai
Vsevolod Katritch
Vsevolod Katritch University of Southern California
Raymond C. Stevens
Raymond C. Stevens University of Southern California
Vadim Cherezov
Vadim Cherezov University of Southern California
Brian K. Shoichet
Brian K. Shoichet University of California, San Francisco
Gye Won Han
Gye Won Han University of Southern California
Ming-Wei Wang
Ming-Wei Wang Chinese Academy of Sciences
Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium
Peter Brown
Peter Brown University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Xi Ping Huang

Trending Scientists

Recently Published Articles